http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235942-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
| filingDate | 2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713dfaee36c90bb1f6d0fb7734884c01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_879a4de38178286e18685ae64ded2c18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9270940d205c9c7652ef74f544002fa0 |
| publicationDate | 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004235942-A1 |
| titleOfInvention | Method for preventing recurring venous thromboembolism using long-term low-intensity warfarin |
| abstract | A method is provided for inhibiting, preventing or reducing the incidence of venous thromboembolism (VTE) in a patient who previously has undergone standard therapy for VTE, that is, a dose of warfarin of 2 to 3 INR over a 3 to 12 month period, wherein the patient is administered a low dose of warfarin of less than 2 INR and preferably from about 1.4 to less than 2 INR over an extended period of time. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113929735-A |
| priorityDate | 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.